Cadrenal Therapeutics, Inc. Common Stock (CVKD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.52M |
| Enterprise Value | 9.51M |
| P/E Ratio | -0.54 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.1 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.15 |
| Return On Equity | -4.11 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.23M |
| Net Income | -13.24M |
| Diluted EPS | -6.64 |
| Total Cash | 2.31M |
| Total Cash/Share | 0.96 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.68 |
| Book Value Per Share | 0.75 |
| 52-Week Change | -72.78 |
| 52-Week High | 14.64 |
| 52-Week Low | 2.94 |
| Moving Average 50 Days | 4.95 |
| Moving Average 200 Days | 8.41 |
| Average Volume | 63,127 |
| Shares Outstanding | 3.08M |
| % Held by Institutions | 3.78 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | August 20, 2024 |